Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,656 JPY | -4.00% | +8.52% | 0.00% |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2022 | 2023 |
---|---|---|
Net sales 1 | 3,947 | 4,742 |
EBITDA | - | - |
EBIT 1 | 971 | 1,268 |
Operating Margin | 24.6% | 26.74% |
Earnings before Tax (EBT) 1 | 922 | 1,243 |
Net income 1 | 587 | 829 |
Net margin | 14.87% | 17.48% |
EPS 2 | 173.3 | 199.0 |
Free Cash Flow | - | - |
FCF margin | - | - |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 3/22/24 | 3/22/24 |
Balance Sheet Analysis
Fiscal Period: March | 2022 | 2023 |
---|---|---|
Net Debt 1 | 493 | 636 |
Net Cash position 1 | - | - |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | - |
ROE (net income / shareholders' equity) | - | 31.7% |
ROA (Net income/ Total Assets) | - | 13.5% |
Assets 1 | - | 6,135 |
Book Value Per Share 2 | 654.0 | 724.0 |
Cash Flow per Share 2 | 512.0 | 351.0 |
Capex | - | - |
Capex / Sales | - | - |
Announcement Date | 3/22/24 | 3/22/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 55.07M | |
+38.69% | 728B | |
+34.28% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+17.02% | 244B | |
+9.31% | 207B | |
-5.07% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- 177A Stock
- Financials Kohjin Bio Co., Ltd.